Fas-mediated apoptosis in Jurkat cells is suppressed in the pre-G2/M phase

Apoptosis

Volumn 4, Issue 4, 1999, Pages 255-261

  Hiroi, N ^a   Maruta, H ^a   Tanuma, S ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Apoptosis; Cell cycle; Fas; G2 M phase; Jurkat cell

Indexed keywords

DNA; FAS ANTIGEN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0032885074     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009652825846     Document Type: Article

References (31)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
2. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 1995; 58: 175-180.
3. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
4. Miyawaki T, Uehara T, Tsuji T, et al. Differential expression of apoptosis-related CD95 antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753-3760.
5. Klas C, Debatin KM, Jonker R, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5: 625-630.
6. Beletskaya IV, Nikonova LV, Beletsky IP. Cell cycle specificity of Fas-mediated apoptosis in WIL-2 cells. FEBS Lett 1997; 412: 91-93.
7. Dao T, Huleatt JW, Hingorani R, Crispe N. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J Immunol 1997; 159: 4261-4267.
8. Li-Weber M, Salgame P, Krammer PH, et al. Differential interaction of nuclear factors with the PRE-1 enhancer element of human IL-4 promoter in different T cell subsets. Blood 1997; 97: 1194-1200.
9. Juo P, Kuo CJ, Reynols SE, et al. Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997; 17: 24-35.
10. Lenczowski JM, Dominguez L, Eder AM, et al. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997; 17: 170-181.
11. Ponton A, Clément M-V, Stamenkovic I. The CD95 (APO-1/Fas) receptor activates NF-kB independently of its cytotoxic function. J Biol Chem 1996; 271: 8991-8995.
12. Eischen CM, Dick CJ, Leibson J. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994; 153: 1947-1954.
13. Shimizu T, O'Connor PM, Kohn KW, Pommier Y. Unscheduled activation of Cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 1995; 55: 228-231.
14. Shiokawa D, Ohyama H, Yamada T, Takahashi K, Tanuma S. Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur J Biochem 1994; 226: 23-30.
15. Tanuma S, Shiokawa D. Multiple forms of nuclear deoxyribonuclease in rat thymocytes. Biochem Biophys Res Comm 1994; 203: 789-797.
16. Huschtscha LI, Jeitner TM, Andersson CE, Bartier WA, Tattersall MHN. Identification of apoptotic and necrotic human leukemic cells by flow cytometry. Exp Cell Res 1994; 212: 161-165.
17. Lacombe F, Belloc F. Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia. Hematol Cell Ther 1996; 38: 495-504.
18. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble from of the Fas molecule. Science 1994; 263: 1759-1762.
19. Schattner EJ, Elkon KB, Yoo D, et al. CD40 ligation induces apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995; 182: 1557-1565.
20. Rathmell JC, Townsend SE, Xu JC, et al. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996; 87: 319-329.
21. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314-317.
22. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969-976.
23. Alderson MR, Armitage RJ, Maraskovsky E, et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 1993; 178: 2231-2235.
24. Dianzani U, Bragardo M, Ramenghi U, et al. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmumty/lymphoproliferation. Blood 1997; 89: 2871-2879.
25. Puck JM, Sneller MC. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Semin Immunol 1997; 9: 77-84.
26. Li F, Ambrosini G, Altieri DC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584.
27. Furukawa Y, Iwase A, Terui J, et al. Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J Biol Chem 1996; 271: 28469-28477.
28. Kitagawa M, Okabe T, Yasuda H, et al. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 1993; 8: 2425-2432.
29. Salvesen GS, Dixit VM. Caspases: intercellular signaling by proteolysis. Cell 1997; 91: 443-446.
30. Shiokawa D, Nishimura K, Maruta H, Tanuma S. DNA fragmentation during thymic apoptosis is catalyzed by DNase γ. Apoptosis 1996; 1: 147-152.
31. Enari M, Sakahira H, Nagata S, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.